Clinical factors are more strongly associated with prognosis than genetic alterations in early-onset colorectal cancer: a retrospective cohort study
- 1University Medical Center HCMC, University of Medicine and Pharmacy
- 2School of Medicine, University of Medicine and Pharmacy
Abstract
Background Early-onset colorectal cancer (EOCRC) is increasing globally and exhibits both aggressive clinicopathological features and distinct molecular characteristics. However, the relative contribution of clinical and genetic factors to prognosis remains unclear, particularly in underrepresented populations. Methods A retrospective cohort study was conducted on 100 colorectal cancer (CRC) patients under 50 years of age, diagnosed and treated between January 2016 and December 2020, with follow-up up to 60 months or until death. Patients were stratified by patient characteristics, oncological features, and genetic mutation status to perform overall survival (OS) analysis. Results The mean OS was 49.8 months (95% CI: 46.4–53.2), with an estimated 5-year OS rate of 65.2%. The mean disease-free survival (DFS) was 50.1 months (95% CI: 46.2–53.9). In univariate analysis, factors significantly associated with OS included serum CEA level at diagnosis (p = 0.001), histological grade (p = 0.006), mode of surgery (emergency vs. elective) (p = 0.003), curative resection status (p < 0.001), disease stage (p < 0.001), mutations in the POL–MMR DNA repair gene group (p = 0.035), high mutation accumulation (p = 0.020), PIK3CA mutation (p = 0.036), and co-mutation of RAS/RAF and MMR genes (p = 0.011). However, when adjusted for disease stage, only patient and oncological factors remained associated with OS, including elevated CEA (HR = 2.33, 95% CI: 1.2–4.7, p = 0.018), poorly differentiated tumors (HR = 2.57, 95% CI: 1.2–5.7, p = 0.021), emergency surgery (HR = 3.50, 95% CI: 1.5–7.9, p = 0.003), and curative treatment (HR = 0.10, 95% CI: 0.05–0.2, p < 0.001). Conclusion In EOCRC, clinical and treatment-related factors remained independently associated with overall survival after adjustment for disease stage, whereas the evaluated genetic variables did not retain statistical significance. These findings highlight the importance of clinical management strategies, while the prognostic value of genetic alterations requires further investigation.
Related
- Smoking-Related Multi-Metal Exposure Associated with Hierarchical Gut Microbiota Alterations in Colorectal Polyp Patients
- Clinical characteristics and prognosis of T1N0M1 lung cancer: a population-based retrospective study
- Tertiary lymphoid structures in the tumor immune microenvironment of EGFR mutation-positive lung cancer are associated with prognosis: a retrospective review.
- An Early Longitudinal Decrease in Platelet Count Is Associated With Poor Prognosis in Acute Myocardial Infarction Patients: A Multicenter Retrospective Study.
- Clinical characteristics and prognosis of liver injury in patients receiving immune checkpoint inhibitor-based therapy: a real-world retrospective study
BibTeX
@article{le2026clinical,
title = {{Clinical factors are more strongly associated with prognosis than genetic alterations in early-onset colorectal cancer: a retrospective cohort study}},
author = {Kien Trung Le and Huy Duc Tran and Minh Duc Do and Thinh Huu Nguyen and Tin Trung Nguyen and Trung Thien Tran},
journal = {BMC Cancer},
year = {2026},
month = jun,
doi = {10.1186/s12885-026-16331-5},
url = {https://doi.org/10.1186/s12885-026-16331-5},
note = {CC BY},
}
RIS
TY - JOUR
TI - Clinical factors are more strongly associated with prognosis than genetic alterations in early-onset colorectal cancer: a retrospective cohort study
AU - Kien Trung Le
AU - Huy Duc Tran
AU - Minh Duc Do
AU - Thinh Huu Nguyen
AU - Tin Trung Nguyen
AU - Trung Thien Tran
PY - 2026
DA - 2026/06/01
JO - BMC Cancer
DO - 10.1186/s12885-026-16331-5
UR - https://doi.org/10.1186/s12885-026-16331-5
AB - Background Early-onset colorectal cancer (EOCRC) is increasing globally and exhibits both aggressive clinicopathological features and distinct molecular characteristics. However, the relative contribution of clinical and genetic factors to prognosis remains unclear, particularly in underrepresented populations. Methods A retrospective cohort study was conducted on 100 colorectal cancer (CRC) patients under 50 years of age, diagnosed and treated between January 2016 and December 2020, with follow-up up to 60 months or until death. Patients were stratified by patient characteristics, oncological features, and genetic mutation status to perform overall survival (OS) analysis. Results The mean OS was 49.8 months (95% CI: 46.4–53.2), with an estimated 5-year OS rate of 65.2%. The mean disease-free survival (DFS) was 50.1 months (95% CI: 46.2–53.9). In univariate analysis, factors significantly associated with OS included serum CEA level at diagnosis (p = 0.001), histological grade (p = 0.006), mode of surgery (emergency vs. elective) (p = 0.003), curative resection status (p < 0.001), disease stage (p < 0.001), mutations in the POL–MMR DNA repair gene group (p = 0.035), high mutation accumulation (p = 0.020), PIK3CA mutation (p = 0.036), and co-mutation of RAS/RAF and MMR genes (p = 0.011). However, when adjusted for disease stage, only patient and oncological factors remained associated with OS, including elevated CEA (HR = 2.33, 95% CI: 1.2–4.7, p = 0.018), poorly differentiated tumors (HR = 2.57, 95% CI: 1.2–5.7, p = 0.021), emergency surgery (HR = 3.50, 95% CI: 1.5–7.9, p = 0.003), and curative treatment (HR = 0.10, 95% CI: 0.05–0.2, p < 0.001). Conclusion In EOCRC, clinical and treatment-related factors remained independently associated with overall survival after adjustment for disease stage, whereas the evaluated genetic variables did not retain statistical significance. These findings highlight the importance of clinical management strategies, while the prognostic value of genetic alterations requires further investigation.
SN - 1471-2407
ER -